1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Gastrointestinal Tract Human Micobiome 1.2.3 Urogenital Tract Human Micobiome 1.2.4 Others 1.3 Market by Application 1.3.1 Global Human Microbiome Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Treatment 1.3.3 Diagnosis 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Human Microbiome Market Perspective (2017-2028) 2.2 Human Microbiome Growth Trends by Region 2.2.1 Human Microbiome Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Human Microbiome Historic Market Size by Region (2017-2022) 2.2.3 Human Microbiome Forecasted Market Size by Region (2023-2028) 2.3 Human Microbiome Market Dynamics 2.3.1 Human Microbiome Industry Trends 2.3.2 Human Microbiome Market Drivers 2.3.3 Human Microbiome Market Challenges 2.3.4 Human Microbiome Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Human Microbiome Players by Revenue 3.1.1 Global Top Human Microbiome Players by Revenue (2017-2022) 3.1.2 Global Human Microbiome Revenue Market Share by Players (2017-2022) 3.2 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Human Microbiome Revenue 3.4 Global Human Microbiome Market Concentration Ratio 3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2021 3.5 Human Microbiome Key Players Head office and Area Served 3.6 Key Players Human Microbiome Product Solution and Service 3.7 Date of Enter into Human Microbiome Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Human Microbiome Breakdown Data by Type 4.1 Global Human Microbiome Historic Market Size by Type (2017-2022) 4.2 Global Human Microbiome Forecasted Market Size by Type (2023-2028) 5 Human Microbiome Breakdown Data by Application 5.1 Global Human Microbiome Historic Market Size by Application (2017-2022) 5.2 Global Human Microbiome Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Human Microbiome Market Size (2017-2028) 6.2 North America Human Microbiome Market Size by Country (2017-2022) 6.3 North America Human Microbiome Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Human Microbiome Market Size (2017-2028) 7.2 Europe Human Microbiome Market Size by Country (2017-2022) 7.3 Europe Human Microbiome Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Human Microbiome Market Size (2017-2028) 8.2 Asia-Pacific Human Microbiome Market Size by Country (2017-2022) 8.3 Asia-Pacific Human Microbiome Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Human Microbiome Market Size (2017-2028) 9.2 Latin America Human Microbiome Market Size by Country (2017-2022) 9.3 Latin America Human Microbiome Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Human Microbiome Market Size (2017-2028) 10.2 Middle East & Africa Human Microbiome Market Size by Country (2017-2022) 10.3 Middle East & Africa Human Microbiome Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Vedanta 11.1.1 Vedanta Company Detail 11.1.2 Vedanta Business Overview 11.1.3 Vedanta Human Microbiome Introduction 11.1.4 Vedanta Revenue in Human Microbiome Business (2017-2022) 11.1.5 Vedanta Recent Development 11.2 Seres Therapeutics 11.2.1 Seres Therapeutics Company Detail 11.2.2 Seres Therapeutics Business Overview 11.2.3 Seres Therapeutics Human Microbiome Introduction 11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2017-2022) 11.2.5 Seres Therapeutics Recent Development 11.3 Second Genome 11.3.1 Second Genome Company Detail 11.3.2 Second Genome Business Overview 11.3.3 Second Genome Human Microbiome Introduction 11.3.4 Second Genome Revenue in Human Microbiome Business (2017-2022) 11.3.5 Second Genome Recent Development 11.4 Rebiotix 11.4.1 Rebiotix Company Detail 11.4.2 Rebiotix Business Overview 11.4.3 Rebiotix Human Microbiome Introduction 11.4.4 Rebiotix Revenue in Human Microbiome Business (2017-2022) 11.4.5 Rebiotix Recent Development 11.5 ActoGeniX 11.5.1 ActoGeniX Company Detail 11.5.2 ActoGeniX Business Overview 11.5.3 ActoGeniX Human Microbiome Introduction 11.5.4 ActoGeniX Revenue in Human Microbiome Business (2017-2022) 11.5.5 ActoGeniX Recent Development 11.6 Enterome BioScience 11.6.1 Enterome BioScience Company Detail 11.6.2 Enterome BioScience Business Overview 11.6.3 Enterome BioScience Human Microbiome Introduction 11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2017-2022) 11.6.5 Enterome BioScience Recent Development 11.7 AvidBiotics 11.7.1 AvidBiotics Company Detail 11.7.2 AvidBiotics Business Overview 11.7.3 AvidBiotics Human Microbiome Introduction 11.7.4 AvidBiotics Revenue in Human Microbiome Business (2017-2022) 11.7.5 AvidBiotics Recent Development 11.8 4D Pharma Research Ltd 11.8.1 4D Pharma Research Ltd Company Detail 11.8.2 4D Pharma Research Ltd Business Overview 11.8.3 4D Pharma Research Ltd Human Microbiome Introduction 11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2017-2022) 11.8.5 4D Pharma Research Ltd Recent Development 11.9 Enterologics 11.9.1 Enterologics Company Detail 11.9.2 Enterologics Business Overview 11.9.3 Enterologics Human Microbiome Introduction 11.9.4 Enterologics Revenue in Human Microbiome Business (2017-2022) 11.9.5 Enterologics Recent Development 11.10 Metabogen 11.10.1 Metabogen Company Detail 11.10.2 Metabogen Business Overview 11.10.3 Metabogen Human Microbiome Introduction 11.10.4 Metabogen Revenue in Human Microbiome Business (2017-2022) 11.10.5 Metabogen Recent Development 11.11 Metabiomics 11.11.1 Metabiomics Company Detail 11.11.2 Metabiomics Business Overview 11.11.3 Metabiomics Human Microbiome Introduction 11.11.4 Metabiomics Revenue in Human Microbiome Business (2017-2022) 11.11.5 Metabiomics Recent Development 11.12 Ritter Pharmaceuticals 11.12.1 Ritter Pharmaceuticals Company Detail 11.12.2 Ritter Pharmaceuticals Business Overview 11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction 11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2017-2022) 11.12.5 Ritter Pharmaceuticals Recent Development 11.13 Osel 11.13.1 Osel Company Detail 11.13.2 Osel Business Overview 11.13.3 Osel Human Microbiome Introduction 11.13.4 Osel Revenue in Human Microbiome Business (2017-2022) 11.13.5 Osel Recent Development 11.14 Symberix 11.14.1 Symberix Company Detail 11.14.2 Symberix Business Overview 11.14.3 Symberix Human Microbiome Introduction 11.14.4 Symberix Revenue in Human Microbiome Business (2017-2022) 11.14.5 Symberix Recent Development 11.15 Miomics 11.15.1 Miomics Company Detail 11.15.2 Miomics Business Overview 11.15.3 Miomics Human Microbiome Introduction 11.15.4 Miomics Revenue in Human Microbiome Business (2017-2022) 11.15.5 Miomics Recent Development 11.16 Symbiotix Biotherapies 11.16.1 Symbiotix Biotherapies Company Detail 11.16.2 Symbiotix Biotherapies Business Overview 11.16.3 Symbiotix Biotherapies Human Microbiome Introduction 11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2017-2022) 11.16.5 Symbiotix Biotherapies Recent Development 11.17 MicroBiome Therapeutics LLC 11.17.1 MicroBiome Therapeutics LLC Company Detail 11.17.2 MicroBiome Therapeutics LLC Business Overview 11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction 11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2017-2022) 11.17.5 MicroBiome Therapeutics LLC Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Gastrointestinal Tract Human Micobiome Table 3. Key Players of Urogenital Tract Human Micobiome Table 4. Key Players of Others Table 5. Global Human Microbiome Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Human Microbiome Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Human Microbiome Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Human Microbiome Market Share by Region (2017-2022) Table 9. Global Human Microbiome Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Human Microbiome Market Share by Region (2023-2028) Table 11. Human Microbiome Market Trends Table 12. Human Microbiome Market Drivers Table 13. Human Microbiome Market Challenges Table 14. Human Microbiome Market Restraints Table 15. Global Human Microbiome Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Human Microbiome Market Share by Players (2017-2022) Table 17. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2021) Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Human Microbiome Product Solution and Service Table 22. Date of Enter into Human Microbiome Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Human Microbiome Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Human Microbiome Revenue Market Share by Type (2017-2022) Table 26. Global Human Microbiome Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Human Microbiome Revenue Market Share by Type (2023-2028) Table 28. Global Human Microbiome Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Human Microbiome Revenue Market Share by Application (2017-2022) Table 30. Global Human Microbiome Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Human Microbiome Revenue Market Share by Application (2023-2028) Table 32. North America Human Microbiome Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Human Microbiome Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Human Microbiome Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Human Microbiome Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Human Microbiome Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Human Microbiome Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Human Microbiome Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Human Microbiome Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Human Microbiome Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Human Microbiome Market Size by Country (2023-2028) & (US$ Million) Table 42. Vedanta Company Detail Table 43. Vedanta Business Overview Table 44. Vedanta Human Microbiome Product Table 45. Vedanta Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 46. Vedanta Recent Development Table 47. Seres Therapeutics Company Detail Table 48. Seres Therapeutics Business Overview Table 49. Seres Therapeutics Human Microbiome Product Table 50. Seres Therapeutics Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 51. Seres Therapeutics Recent Development Table 52. Second Genome Company Detail Table 53. Second Genome Business Overview Table 54. Second Genome Human Microbiome Product Table 55. Second Genome Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 56. Second Genome Recent Development Table 57. Rebiotix Company Detail Table 58. Rebiotix Business Overview Table 59. Rebiotix Human Microbiome Product Table 60. Rebiotix Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 61. Rebiotix Recent Development Table 62. ActoGeniX Company Detail Table 63. ActoGeniX Business Overview Table 64. ActoGeniX Human Microbiome Product Table 65. ActoGeniX Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 66. ActoGeniX Recent Development Table 67. Enterome BioScience Company Detail Table 68. Enterome BioScience Business Overview Table 69. Enterome BioScience Human Microbiome Product Table 70. Enterome BioScience Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 71. Enterome BioScience Recent Development Table 72. AvidBiotics Company Detail Table 73. AvidBiotics Business Overview Table 74. AvidBiotics Human Microbiome Product Table 75. AvidBiotics Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 76. AvidBiotics Recent Development Table 77. 4D Pharma Research Ltd Company Detail Table 78. 4D Pharma Research Ltd Business Overview Table 79. 4D Pharma Research Ltd Human Microbiome Product Table 80. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 81. 4D Pharma Research Ltd Recent Development Table 82. Enterologics Company Detail Table 83. Enterologics Business Overview Table 84. Enterologics Human Microbiome Product Table 85. Enterologics Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 86. Enterologics Recent Development Table 87. Metabogen Company Detail Table 88. Metabogen Business Overview Table 89. Metabogen Human Microbiome Product Table 90. Metabogen Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 91. Metabogen Recent Development Table 92. Metabiomics Company Detail Table 93. Metabiomics Business Overview Table 94. Metabiomics Human MicrobiomeProduct Table 95. Metabiomics Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 96. Metabiomics Recent Development Table 97. Ritter Pharmaceuticals Company Detail Table 98. Ritter Pharmaceuticals Business Overview Table 99. Ritter Pharmaceuticals Human MicrobiomeProduct Table 100. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 101. Ritter Pharmaceuticals Recent Development Table 102. Osel Company Detail Table 103. Osel Business Overview Table 104. Osel Human MicrobiomeProduct Table 105. Osel Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 106. Osel Recent Development Table 107. Symberix Company Detail Table 108. Symberix Business Overview Table 109. Symberix Human MicrobiomeProduct Table 110. Symberix Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 111. Symberix Recent Development Table 112. Miomics Company Detail Table 113. Miomics Business Overview Table 114. Miomics Human MicrobiomeProduct Table 115. Miomics Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 116. Miomics Recent Development Table 117. Symbiotix Biotherapies Company Detail Table 118. Symbiotix Biotherapies Business Overview Table 119. Symbiotix Biotherapies Human MicrobiomeProduct Table 120. Symbiotix Biotherapies Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 121. Symbiotix Biotherapies Recent Development Table 122. MicroBiome Therapeutics LLC Company Detail Table 123. MicroBiome Therapeutics LLC Business Overview Table 124. MicroBiome Therapeutics LLC Human MicrobiomeProduct Table 125. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2017-2022) & (US$ Million) Table 126. MicroBiome Therapeutics LLC Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Microbiome Market Share by Type: 2021 VS 2028 Figure 2. Gastrointestinal Tract Human Micobiome Features Figure 3. Urogenital Tract Human Micobiome Features Figure 4. Others Features Figure 5. Global Human Microbiome Market Share by Application in 2021 & 2028 Figure 6. Treatment Case Studies Figure 7. Diagnosis Case Studies Figure 8. Human Microbiome Report Years Considered Figure 9. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Human Microbiome Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Human Microbiome Market Share by Region: 2021 VS 2028 Figure 12. Global Human Microbiome Market Share by Players in 2021 Figure 13. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2021 Figure 15. North America Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Human Microbiome Market Share by Country (2017-2028) Figure 17. United States Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Human Microbiome Market Share by Country (2017-2028) Figure 21. Germany Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Human Microbiome Market Share by Region (2017-2028) Figure 29. China Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Human Microbiome Market Share by Country (2017-2028) Figure 37. Mexico Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Human Microbiome Market Share by Country (2017-2028) Figure 41. Turkey Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Vedanta Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 44. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 45. Second Genome Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 46. Rebiotix Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 47. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 48. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 49. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 50. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 51. Enterologics Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 52. Metabogen Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 53. Metabiomics Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 54. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 55. Osel Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 56. Symberix Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 57. Miomics Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 58. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 59. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2017-2022) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Vedanta Seres Therapeutics Second Genome Rebiotix ActoGeniX Enterome BioScience AvidBiotics 4D Pharma Research Ltd Enterologics Metabogen Metabiomics Ritter Pharmaceuticals Osel Symberix Miomics Symbiotix Biotherapies MicroBiome Therapeutics LLC